Implementation of pro- and anti-inflammatory mechanisms of sirtuin-1 in patients with chronic obstructive pulmonary disease and chronic coronary syndrome and their combination
DOI:
https://doi.org/10.14739/2310-1210.2023.4.276009Keywords:
sirtuin 1, high sensitivity C-reactive protein, nitric oxide synthase type III, chronic obstructive pulmonary disease, chronic coronary syndromeAbstract
One of the key pathogenetic aspects of chronic obstructive pulmonary disease (COPD) and chronic coronary syndrome (CCS) is endothelial dysfunction. Further study on this pathological process is relevant for a better understanding of the course and increasing the treatment effectiveness of these diseases. In this context, in recent years, there has been a growing body of evidence about sirtuins which, according to the latest research results, were capable of rebalancing vasoconstrictory and vasodilatory mediators, regulating the balance in the protease-antiprotease system, protecting endothelial cells from oxidative stress and may be useful in relation to the pathogenesis of COPD and CCS.
Aim. To study changes in the levels of serum endothelial nitric oxide synthase (NOS3/eNOS) and sirtuin 1 (SIRT1) in patients with a combined course of COPD and CCS and with COPD or CCS alone.
Materials and methods. In order to study endothelial dysfunction and the role of SIRT1 in the processes of its development, we examined 60 patients with combined course of COPD and with CCS or COPD alone. The control group included 10 apparently healthy individuals. Levels of SIRT1 and NOS3/eNOS were studied by enzyme-linked immunosorbent assay, and high-sensitivity C-reactive protein (hsCRP) – by immunoturbidimetric method; clinical data and medical records were analyzed. Commonplace statistical analyses were used.
Results. The results have shown that the serum level of SIRT1 in patients with COPD and CCS was lower than that in the control group. The level of hsCRP was significantly higher in patients with the studied pathology than that in apparently healthy individuals and was the highest in patients with combined COPD and CCS. The study on serum NOS3/eNOS has showed the highest concentration in COPD patients, and it was significantly higher in all groups of patients with the studied pathology than that in healthy individuals. A direct correlation has been found between the serum level of SIRT1 and hsCRP and an inverse correlation – with the level of NOS3/eNOS.
Conclusions. Thus, the pleiotropic effects and multifaceted molecular interactions of SIRT1 are a promising direction in the search for effective new therapeutic strategies in COPD and CCS.
References
World Health Organization. (2020, 9 December). The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
Aslani, M. R., Matin, S., Nemati, A., Mesgari-Abbasi, M., Ghorbani, S., & Ghobadi, H. (2020). Effects of conjugated linoleic acid supplementation on serum levels of interleukin-6 and sirtuin 1 in COPD patients. Avicenna journal of phytomedicine, 10(3), 305-315.
Global initiative for chronic obstructive lung disease. (2020). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf
Polverino, F., Celli, B. R., & Owen, C. A. (2018). COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulmonary circulation, 8(1), 2045894018758528. https://doi.org/10.1177/2045894018758528
Huertas, A., Guignabert, C., Barberà, J. A., Bärtsch, P., Bhattacharya, J., Bhattacharya, S., Bonsignore, M. R., Dewachter, L., Dinh-Xuan, A. T., Dorfmüller, P., Gladwin, M. T., Humbert, M., Kotsimbos, T., Vassilakopoulos, T., Sanchez, O., Savale, L., Testa, U., & Wilkins, M. R. (2018). Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: Highlights from basic research to therapy. The European respiratory journal, 51(4), 1700745. https://doi.org/10.1183/13993003.00745-2017
Aggarwal, S., Banerjee, S. K., Talukdar, N. C., & Yadav, A. K. (2020). Post-translational Modification Crosstalk and Hotspots in Sirtuin Interactors Implicated in Cardiovascular Diseases. Frontiers in genetics, 11, 356. https://doi.org/10.3389/fgene.2020.00356
Kane, A. E., & Sinclair, D. A. (2018). Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases. Circulation research, 123(7), 868-885. https://doi.org/10.1161/CIRCRESAHA.118.312498
D'Onofrio, N., Servillo, L., & Balestrieri, M. L. (2018). SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection. Antioxidants & redox signaling, 28(8), 711-732. https://doi.org/10.1089/ars.2017.7178
Li, P., Liu, Y., Burns, N., Zhao, K. S., & Song, R. (2017). SIRT1 is required for mitochondrial biogenesis reprogramming in hypoxic human pulmonary arteriolar smooth muscle cells. International journal of molecular medicine, 39(5), 1127-1136. https://doi.org/10.3892%2Fijmm.2017.2932
Stupchuk, M. S., & Voznesenskaja, T. Yu. (2017). Biolohichna rol syrtuiniv v eukariotiv [Biological effects and properties of eukaryotic sirtuins]. Fiziolohichnyi zhurnal, 63(4), 105-113. [in Ukrainian]. https://doi.org/10.15407/fz63.04.105
Hodge, G., Tran, H. B., Reynolds, P. N., Jersmann, H., & Hodge, S. (2020). Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes. Therapeutic advances in respiratory disease, 14, 1753466620905280. https://doi.org/10.1177/1753466620905280
Conti, V., Corbi, G., Manzo, V., Malangone, P., Vitale, C., Maglio, A., Cotugno, R., Capaccio, D., Marino, L., Selleri, C., Stellato, C., Filippelli, A., & Vatrella, A. (2018). SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease. Oxidative medicine and cellular longevity, 2018, 9391261. https://doi.org/10.1155/2018/9391261
Zhou, S., Dai, Y. M., Zeng, X. F., & Chen, H. Z. (2020). Circadian Clock and Sirtuins in Diabetic Lung: A Mechanistic Perspective. Frontiers in endocrinology, 11, 173. https://doi.org/10.3389/fendo.2020.00173
Grabowska, W., Sikora, E., & Bielak-Zmijewska, A. (2017). Sirtuins, a promising target in slowing down the ageing process. Biogerontology, 18(4), 447-476. https://doi.org/10.1007/s10522-017-9685-9
Di Vincenzo, S., Heijink, I. H., Noordhoek, J. A., Cipollina, C., Siena, L., Bruno, A., Ferraro, M., Postma, D. S., Gjomarkaj, M., & Pace, E. (2018). SIRT1/FoxO3 axis alteration leads to aberrant immune responses in bronchial epithelial cells. Journal of cellular and molecular medicine, 22(4), 2272-2282. https://doi.org/10.1111/jcmm.13509
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
